Scilex Holding Company (NASDAQ:SCLX) has a beta value of 0.98 and has seen 1.19 million shares traded in the last trading session. The SCLX stock price is -415.69% off its 52-week high price of $2.63 and 9.8% above the 52-week low of $0.46. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.67 million shares traded. The 3-month trading volume is 2.11 million shares.
The consensus among analysts is that Scilex Holding Company (SCLX) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.1.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Scilex Holding Company (NASDAQ:SCLX) trade information
Sporting -1.42% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the SCLX stock price touched $0.51 or saw a rise of 30.23%. Year-to-date, Scilex Holding Company shares have moved -75.12%, while the 5-day performance has seen it change -21.56%. Over the past 30 days, the shares of Scilex Holding Company (NASDAQ:SCLX) have changed -31.42%. Short interest in the company has seen 6.14 million shares shorted with days to cover at 2.23.
Scilex Holding Company (SCLX) estimates and forecasts
Figures show that Scilex Holding Company shares have outperformed across the wider relevant industry. The company’s shares have lost -68.48% over the past 6 months, with this year growth rate of 28.23%, compared to 16.90% for the industry. Revenue growth from the last financial year stood is estimated to be 30.17%.
4 analysts offering their estimates for the company have set an average revenue estimate of 15.64M for the current quarter. 4 have an estimated revenue figure of 19.14M for the next ending quarter. Year-ago sales stood 10.12M and 13.46M respectively for this quarter and the next, and analysts expect sales will grow by 54.58% for the current quarter and 30.17% for the next.
SCLX Dividends
Scilex Holding Company is expected to release its next earnings report in January this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Scilex Holding Company (NASDAQ:SCLX)’s Major holders
Insiders own 32.79% of the company shares, while shares held by institutions stand at 18.15% with a share float percentage of 27.00%. Investors are also buoyed by the number of investors in a company, with Scilex Holding Company having a total of 148.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF and Vanguard Total Stock Market Index Fund . As of Sep 30, 2024 , the former fund manager holds about 3.10% shares in the company for having 5.94 shares of worth $3.01 million while later fund manager owns 3.71 shares of worth $1.88 million as of Sep 30, 2024 , which makes it owner of about 1.94% of company’s outstanding stock.
